{"id": "CZhQ1cgAAAAJ", "citedby": 2786, "citedby5y": 1513, "hindex": 25, "hindex5y": 18, "i10index": 46, "i10index5y": 31, "coauthors": [], "name": "David Harold Drewry", "affiliation": "Associate Professor University of North Carolina Chapel Hill", "interests": ["Medicinal Chemistry"], "cites_per_year": {"1994": 20, "1995": 52, "1996": 54, "1997": 45, "1998": 45, "1999": 58, "2000": 62, "2001": 62, "2002": 58, "2003": 69, "2004": 60, "2005": 47, "2006": 50, "2007": 44, "2008": 35, "2009": 43, "2010": 63, "2011": 68, "2012": 116, "2013": 84, "2014": 110, "2015": 166, "2016": 218, "2017": 228, "2018": 307, "2019": 386, "2020": 208}, "publications": [{"bib": {"title": "Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor", "year": "1994"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:u5HHmVD_uO8C", "citedby": "362"}, {"bib": {"title": "Solid\u2010supported reagents in organic synthesis", "year": "1999"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:u-x6o8ySG0sC", "citedby": "186"}, {"bib": {"title": "Comprehensive characterization of the published kinase inhibitor set", "year": "2016"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:aqlVkmm33-oC", "citedby": "174"}, {"bib": {"title": "Assessment of chemical coverage of kinome space and its implications for kinase drug discovery", "year": "2008"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:d1gkVwhDpl0C", "citedby": "158"}, {"bib": {"title": "New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource", "year": "2015"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:0EnyYjriUFMC", "citedby": "151"}, {"bib": {"title": "Enhancements of screening collections to address areas of unmet medical need: an industry perspective", "year": "2010"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:2osOgNQ5qMEC", "citedby": "132"}, {"bib": {"title": "A public-private partnership to unlock the untargeted kinome", "year": "2012"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:qjMakFHDy7sC", "citedby": "128"}, {"bib": {"title": "Discovery of I-BRD9, a selective cell active chemical probe for bromodomain containing protein 9 inhibition", "year": "2016"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:hqOjcs7Dif8C", "citedby": "119"}, {"bib": {"title": "Discovery and characterization of GSK2801, a selective chemical probe for the bromodomains BAZ2A and BAZ2B", "year": "2016"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:5nxA0vEk-isC", "citedby": "92"}, {"bib": {"title": "Solid-phase synthesis of trisubstituted guanidines", "year": "1997"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:9yKSN-GCB0IC", "citedby": "90"}, {"bib": {"title": "Seeding collaborations to advance kinase science with the GSK Published Kinase Inhibitor Set (PKIS)", "year": "2014"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:roLk4NBRz8UC", "citedby": "85"}, {"bib": {"title": "Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase", "year": "2010"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:IjCSPb-OGe4C", "citedby": "81"}, {"bib": {"title": "Plasmodium kinases as targets for new-generation antimalarials", "year": "2012"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:Y0pCki6q_DkC", "citedby": "68"}, {"bib": {"title": "Progress towards a public chemogenomic set for protein kinases and a call for contributions", "year": "2017"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:ns9cj8rnVeAC", "citedby": "65"}, {"bib": {"title": "Matrix Metalloproteinase Inhibitors Containing a [(Carboxyalkyl) amino] zinc Ligand: Modification of the P1 and P2'Residues", "year": "1994"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:UeHWp8X0CEIC", "citedby": "55"}, {"bib": {"title": "Approaches to the design of combinatorial libraries", "year": "1999"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:zYLM7Y9cAGgC", "citedby": "53"}, {"bib": {"title": "Quantitative, wide-spectrum kinase profiling in live cells for assessing the effect of cellular ATP on target engagement", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:2P1L_qKh6hAC", "citedby": "51"}, {"bib": {"title": "Profile of the GSK published protein kinase inhibitor set across ATP-dependent and-independent luciferases: implications for reporter-gene assays", "year": "2013"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:_FxGoFyzp5QC", "citedby": "50"}, {"bib": {"title": "Optimization of focused chemical libraries using recursive partitioning", "year": "2002"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:Tyk-4Ss8FVUC", "citedby": "43"}, {"bib": {"title": "EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen", "year": "2016"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:JV2RwH3_ST0C", "citedby": "35"}, {"bib": {"title": "Discovery of thiophene inhibitors of polo-like kinase", "year": "2009"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:YsMSGLbcyi4C", "citedby": "34"}, {"bib": {"title": "A Rapid Three-Component MgI2-Mediated Synthesis of 3,3-Pyrollidinyl Spirooxindoles", "year": "2010"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:ufrVoPGSRksC", "citedby": "33"}, {"bib": {"title": "Structure-bioactivity relationship for benzimidazole thiophene inhibitors of polo-like kinase 1 (PLK1), a potential drug target in Schistosoma mansoni", "year": "2016"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:R3hNpaxXUhUC", "citedby": "32"}, {"bib": {"title": "Solid-phase synthesis of 2-aminoimidazolinones", "year": "2000"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:W7OEmFMy1HYC", "citedby": "27"}, {"bib": {"title": "2-Amino-4, 6-diarylpyridines as novel ligands for the estrogen receptor", "year": "2001"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:eQOLeE2rZwMC", "citedby": "26"}, {"bib": {"title": "Kinase-targeted library design through the application of the PharmPrint methodology", "year": "2008"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:Se3iqnhoufwC", "citedby": "24"}, {"bib": {"title": "Inhibition of thermolysin by phosphonamidate transition-state analogues: measurement of 31P-15N bond lengths and chemical shifts in two enzyme-inhibitor complexes by solid \u2026", "year": "1990"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:LkGwnXOMwfcC", "citedby": "24"}, {"bib": {"title": "Kinase drug discovery: modern approaches", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:YOwf2qJgpHMC", "citedby": "23"}, {"bib": {"title": "Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:a0OBvERweLwC", "citedby": "22"}, {"bib": {"title": "Aminobutanoic acid compounds having metalloprotease inhibiting properties", "year": "1994"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:MXK_kJrjxJIC", "citedby": "21"}, {"bib": {"title": "Rapid synthesis of novel dipeptide inhibitors of human collagenase and gelatinase using solid phase chemistry", "year": "1996"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:WF5omc3nYNoC", "citedby": "20"}, {"bib": {"title": "SGC-GAK-1: a chemical probe for cyclin G associated kinase (GAK)", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:OU6Ihb5iCvQC", "citedby": "19"}, {"bib": {"title": "Science Forum: Donated chemical probes for open science", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:rO6llkc54NcC", "citedby": "19"}, {"bib": {"title": "New synthetic approaches to estrogen receptor modulators: imidazo [1, 2-a] pyridines", "year": "2003"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:UebtZRa9Y70C", "citedby": "19"}, {"bib": {"title": "A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific inhibitors of the Listeria monocytogenes PASTA kinase PrkA", "year": "2017"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:35N4QoGY0k4C", "citedby": "14"}, {"bib": {"title": "Thiophene compounds", "year": "2006"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:4DMP91E08xMC", "citedby": "14"}, {"bib": {"title": "Design of a cyclin G associated kinase (GAK)/epidermal growth factor receptor (EGFR) inhibitor set to interrogate the relationship of EGFR and GAK in chordoma", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:p2g8aNsByqUC", "citedby": "12"}, {"bib": {"title": "New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:dshw04ExmUIC", "citedby": "12"}, {"bib": {"title": "In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:NaGl4SEjCO4C", "citedby": "11"}, {"bib": {"title": "Array synthesis of progesterone receptor antagonists: 3-Aryl-1, 2-diazepines", "year": "2006"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:3fE2CSJIrl8C", "citedby": "11"}, {"bib": {"title": "Discovery of a Potent and Selective \u03b11A Antagonist", "year": "2002"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:8k81kl-MbHgC", "citedby": "11"}, {"bib": {"title": "CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:XiSMed-E-HIC", "citedby": "10"}, {"bib": {"title": "WNT activates the AAK1 kinase to promote clathrin-mediated endocytosis of LRP6 and establish a negative feedback loop", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:xtRiw3GOFMkC", "citedby": "10"}, {"bib": {"title": "1, 2, 6-thiadiazinones as novel narrow spectrum calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2) Inhibitors", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:4OULZ7Gr8RgC", "citedby": "10"}, {"bib": {"title": "High-throughput manual parallel synthesis using SynPhase crowns and lanterns", "year": "2003"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:KlAtU1dfN6UC", "citedby": "10"}, {"bib": {"title": "2-(Anilinomethyl) imidazolines as \u03b11A Adrenergic Receptor Agonists: 2\u2032-Heteroaryl and 2\u2032-Oxime Ether Series", "year": "2002"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:kNdYIx-mwKoC", "citedby": "10"}, {"bib": {"title": "E2F1 proteolysis via SCF\u2010cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:l7t_Zn2s7bgC", "citedby": "9"}, {"bib": {"title": "GW779439X and its pyrazolopyridazine derivatives inhibit the serine/threonine kinase Stk1 and act as antibiotic adjuvants against \u03b2-lactam-resistant Staphylococcus aureus", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:yD5IFk8b50cC", "citedby": "9"}, {"bib": {"title": "Chemical Compounds", "year": "2008"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:L8Ckcad2t8MC", "citedby": "9"}, {"bib": {"title": "Aminopyridine derivatives as estrogen receptor modulators", "year": "2007"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:4JMBOYKVnBMC", "citedby": "9"}, {"bib": {"title": "Formamides as therapeutic agents", "year": "2001"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:ULOm3_A8WrAC", "citedby": "9"}, {"bib": {"title": "An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent model", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:SeFeTyx0c_EC", "citedby": "8"}, {"bib": {"title": "Inhibitors of Akt Activity", "year": "2008"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:maZDTaKrznsC", "citedby": "8"}, {"bib": {"title": "The kinome and its impact on medicinal chemistry", "year": "2012"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:IWHjjKOFINEC", "citedby": "7"}, {"bib": {"title": "Cyclic imide derivatives, compositions and use", "year": "1993"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:_kc_bZDykSQC", "citedby": "6"}, {"bib": {"title": "Highly selective MERTK inhibitors achieved by a single methyl group", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:pyW8ca7W8N0C", "citedby": "5"}, {"bib": {"title": "New tools for carbohydrate sulfation analysis: heparan sulfate 2-O-sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitors", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:UxriW0iASnsC", "citedby": "5"}, {"bib": {"title": "Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors", "year": "2009"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:dhFuZR0502QC", "citedby": "5"}, {"bib": {"title": "Oxindole derivatives", "year": "2004"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:M3ejUd6NZC8C", "citedby": "5"}, {"bib": {"title": "In silico screen and structural analysis identifies bacterial kinase inhibitors which act with \u03b2-lactams to inhibit mycobacterial growth", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:D03iK_w7-QYC", "citedby": "4"}, {"bib": {"title": "Glucagon receptor antagonists for the treatment of type 2 diabetes.", "year": "2003"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:4TOpqqG69KYC", "citedby": "4"}, {"bib": {"title": "Oxazole derivatives as antagonists of alpha 1C andrenergic receptors", "year": "2000"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:qxL8FJ1GzNcC", "citedby": "4"}, {"bib": {"title": "Drug Discovery and Development for Schistosomiasis", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:K3LRdlH-MEoC", "citedby": "3"}, {"bib": {"title": "Kinase inhibitors among hits from malaria cellular screens", "year": "2013"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:Wp0gIr-vW9MC", "citedby": "3"}, {"bib": {"title": "Benzimidazol-1-YL-thiophene compounds for the treatment of cancer", "year": "2008"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:TFP_iSt0sucC", "citedby": "3"}, {"bib": {"title": "Benzimidazol-1-YL-thiophene compounds for the treatment of cancer", "year": "2008"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:hFOr9nPyWt4C", "citedby": "3"}, {"bib": {"title": "Pyrazolopyrimidines as kinase inhibitors", "year": "2005"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:ZeXyd9-uunAC", "citedby": "3"}, {"bib": {"title": "Binding and structural analyses of potent inhibitors of the human Ca 2+/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially \u2026", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:4fKUyHm3Qg0C", "citedby": "2"}, {"bib": {"title": "Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes", "year": "2017"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:vV6vV6tmYwMC", "citedby": "2"}, {"bib": {"title": "Chemical Compounds", "year": "2008"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:e5wmG9Sq2KIC", "citedby": "2"}, {"bib": {"title": "Compounds", "year": "2007"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:WbkHhVStYXYC", "citedby": "2"}, {"bib": {"title": "Imidazoline derivatives as alpha-1A adrenoceptor ligands", "year": "2005"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:9ZlFYXVOiuMC", "citedby": "2"}, {"bib": {"title": "In depth analysis of kinase cross screening data to identify CAMKK2 inhibitory scaffolds", "year": "2020"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:5Ul4iDaHHb8C", "citedby": "1"}, {"bib": {"title": "SGC-AAK1-1: a chemical probe targeting AAK1 and BMP2K", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:B3FOqHPlNUQC", "citedby": "1"}, {"bib": {"title": "Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:tS2w5q8j5-wC", "citedby": "1"}, {"bib": {"title": "A Perspective on Extreme Open Science: Companies Sharing Compounds without Restriction", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:u9iWguZQMMsC", "citedby": "1"}, {"bib": {"title": "Drugging the Kinome", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:_xSYboBqXhAC", "citedby": "1"}, {"bib": {"title": "Development of narrow spectrum ATP-competitive kinase inhibitors as probes for BIKE and AAK1", "year": "2017"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:GnPB-g6toBAC", "citedby": "1"}, {"bib": {"title": "Investigation of 7-azaindoles as developable kinase inhibitors: identification of GSK1070916 as a highly potent and selective inhibitor of Aurora B kinase", "year": "2008"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:mVmsd5A6BfQC", "citedby": "1"}, {"bib": {"title": "Alpha 1A antagonists for benign prostatic hyperplasia", "year": "1996"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:QIV2ME_5wuYC", "citedby": "1"}, {"bib": {"title": "STRUCTURAL STUDIES OF THERMOLYSIN-INHIBITOR COMPLEXES WITH SOLID-STATE NMR-MEASUREMENTS OF P-31-N-15 BOND LENGTHS AND CHEMICAL-SHIFTS", "year": "1990"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:7PzlFSSx8tAC", "citedby": "1"}, {"bib": {"title": "SGC-CK2-1: The First Selective Chemical Probe for the Pleiotropic Kinase CK2", "year": "2020"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:BrmTIyaxlBUC", "citedby": "0"}, {"bib": {"title": "CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model", "year": "2020"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:eflP2zaiRacC", "citedby": "0"}, {"bib": {"title": "Concise, gram-scale synthesis of furo [2, 3-b] pyridines, with functional handles for chemoselective cross-coupling", "year": "2020"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:VOx2b1Wkg3QC", "citedby": "0"}, {"bib": {"title": "Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases", "year": "2020"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:eJXPG6dFmWUC", "citedby": "0"}, {"bib": {"title": "Identification and Optimization of cell active 4-anilino-quin (az) oline Inhibitors for Protein Kinase Novel 3 (PKN3)", "year": "2020"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:fQNAKQ3IYiAC", "citedby": "0"}, {"bib": {"title": "Crowdsourced mapping of unexplored target space of kinase inhibitors", "year": "2020"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:8AbLer7MMksC", "citedby": "0"}, {"bib": {"title": "Comprehensive Survey of CDK Inhibitor Selectivity in Live Cells with Energy Transfer Probes", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:sSrBHYA8nusC", "citedby": "0"}, {"bib": {"title": "Binding and structural analyses of potent inhibitors of the human Ca2+/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially \u2026", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:LPZeul_q3PIC", "citedby": "0"}, {"bib": {"title": "A Chemical Probe Targeting AAK1 and BMP2K", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:vRqMK49ujn8C", "citedby": "0"}, {"bib": {"title": "CDK16: the pick of the understudied PCTAIRE kinases.", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:738O_yMBCRsC", "citedby": "0"}, {"bib": {"title": "Optimization of structural features of the 4-anilinoquin (az) oline scaffold for chordoma utilizing an innovative toxicology profiling assay panel", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:08ZZubdj9fEC", "citedby": "0"}, {"bib": {"title": "Developing a chemical probe: Thieno [3, 2-d] pyrimidines, selective and potent inhibitors of protein kinase DRAK2/STK17B", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:tOudhMTPpwUC", "citedby": "0"}, {"bib": {"title": "The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:geHnlv5EZngC", "citedby": "0"}, {"bib": {"title": "Targeting destabilized DNA G-quadruplexes and aberrant splicing in drug-resistant glioblastoma", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:Tiz5es2fbqcC", "citedby": "0"}, {"bib": {"title": "Structural and binding studies of human CAMKK2 kinase domain bound to small molecule ligands", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:CHSYGLWDkRkC", "citedby": "0"}, {"bib": {"title": "Cyclin F-Chk1 synthetic lethality mediated by E2F1 degradation", "year": "2019"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:NhqRSupF_l8C", "citedby": "0"}, {"bib": {"title": "Extreme Open Science: Companies Sharing Compounds without Restriction", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:1sJd4Hv_s6UC", "citedby": "0"}, {"bib": {"title": "New Screening Approaches for Kinases", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:bFI3QPDXJZMC", "citedby": "0"}, {"bib": {"title": "Re-defining the oxindole chemotype to identify narrow spectrum inhibitors of the dark kinases TLK2 and PKMYT1", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:EUQCXRtRnyEC", "citedby": "0"}, {"bib": {"title": "Identification of a novel kinase target in DM pathophysiology", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:fPk4N6BV_jEC", "citedby": "0"}, {"bib": {"title": "Abstract P5-05-05: Patient-derived triple negative breast cancer xenografts as a translational model to screen for novel kinase pathways", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:g5m5HwL7SMYC", "citedby": "0"}, {"bib": {"title": "Design of a GAK/EGFR inhibitor set to interrogate the relationship of EGFR and GAK in chordoma", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:b0M2c_1WBrUC", "citedby": "0"}, {"bib": {"title": "A Transcription-uncoupled Negative Feedback Loop for the 1 WNT Pathway: WNT Activates the AAK1 Kinase to Promote Clathrin-mediated Endocytosis of LRP6", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:cFHS6HbyZ2cC", "citedby": "0"}, {"bib": {"title": "Repurposing covalent EGFR/HER2 inhibitors for on-target degradation of human Tribbles 2 (TRIB2) pseudokinase", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:zA6iFVUQeVQC", "citedby": "0"}, {"bib": {"title": "New tools for evaluating protein tyrosine sulphation: Tyrosyl Protein Sulphotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:3s1wT3WcHBgC", "citedby": "0"}, {"bib": {"title": "New tools for carbohydrate sulphation analysis: Heparan Sulphate 2-O-sulphotranserase (HS2ST) is a target for small molecule protein kinase inhibitors", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:ZHo1McVdvXMC", "citedby": "0"}, {"bib": {"title": "AAK1 inhibits WNT signaling by promoting clathrin-mediated endocytosis of LRP6", "year": "2018"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:M05iB0D1s5AC", "citedby": "0"}, {"bib": {"title": "Identification and characterization of a new series of calcium/calmodulin-dependent protein kinase kinase-2 (CAMKK2) inhibitors", "year": "2017"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:u_35RYKgDlwC", "citedby": "0"}, {"bib": {"title": "Triple negative breast cancer patient-derived xenografts as a translational model for discovery of novel therapeutic targets", "year": "2017"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:lSLTfruPkqcC", "citedby": "0"}, {"bib": {"title": "Targeting an unconventional kinase-invasion axis in breast cancer metastasis", "year": "2016"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:NMxIlDl6LWMC", "citedby": "0"}, {"bib": {"title": "HIGH-THROUGHPUT SCREENING OF GLIOMA STEM CELL LINES FOR DRUG STRUCTURE-AND GENOTYPE-CORRELATED SENSITIVITY TO A PANEL OF TYROSINE KINASE INHIBITORS", "year": "2014"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:_Qo2XoVZTnwC", "citedby": "0"}, {"bib": {"title": "Anthranilamide inhibitors of aurora kinase", "year": "2011"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:mB3voiENLucC", "citedby": "0"}, {"bib": {"title": "Aminopyrazine derivatives and compositions", "year": "2009"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:dfsIfKJdRG4C", "citedby": "0"}, {"bib": {"title": "Aminopyrazine derivatives and compositions", "year": "2008"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:bEWYMUwI8FkC", "citedby": "0"}, {"bib": {"title": "Strategies for Discovering Kinase Drugs", "year": "2008"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:qUcmZB5y_30C", "citedby": "0"}, {"bib": {"title": "Compounds", "year": "2008"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:r0BpntZqJG4C", "citedby": "0"}, {"bib": {"title": "indazolylacrylamide derivatives are useful in the treatment of diseases associated with inappropriate SGK-1 activity", "year": "2004"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:HDshCWvjkbEC", "citedby": "0"}, {"bib": {"title": "Mechanism-and structure-based strategies for the design of biologically active compounds", "year": "1995"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:isC4tDSrTZIC", "citedby": "0"}, {"bib": {"title": "Mechanism-and Structure-Derived Strategies for the Design of Biologically Active Compounds", "year": "1995"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:hC7cP41nSMkC", "citedby": "0"}, {"bib": {"title": "APPROACHES TO INHIBITORS OF METALLOPROTEASES", "year": "1994"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:M3NEmzRMIkIC", "citedby": "0"}, {"bib": {"title": "I. Studies on slow-binding phosphonate and phosphonamidate inhibitors of thermolysin. II. Synthesis and evaluation of a serine protease inhibitor mimic.", "year": "1992"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:RHpTSmoSYBkC", "citedby": "0"}, {"bib": {"title": "Inhibition of thermolysin by phosphonamidate transition-state analogs: measurement of phosphorus-31-nitrogen-15 bond lengths and chemical shifts in two enzyme-inhibitor \u2026", "year": "1990"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:iH-uZ7U-co4C", "citedby": "0"}, {"bib": {"title": "Interplay among Enzyme Mechanism, Protein Structure, and the Design of Serine Protease Inhibitors", "year": "1990"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:TQgYirikUcIC", "citedby": "0"}, {"bib": {"title": "Mechanism-and Structure-Derived Strategies for the Design of Biologically Active Compounds", "year": "1989"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:-f6ydRqryjwC", "citedby": "0"}, {"bib": {"title": "Details of the interaction of phosphorus-containing peptide inhibitors with thermolysin", "year": "1988"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:k_IJM867U9cC", "citedby": "0"}, {"bib": {"title": "Details of the Interaction of Phosphorus-Containing Peptide Inhibitors with Thermolysin", "year": "1988"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:j3f4tGmQtD8C", "citedby": "0"}, {"bib": {"title": "T. Hayashi and M. Tanaka"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:pqnbT2bcN3wC", "citedby": "0"}, {"bib": {"title": "Cover Photograph, Bioorganic & Medicinal Chemistry Letters 2002: Representation of the inhibitor celecoxib in the active site of the COX-2 enzyme. The model has been derived \u2026"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:ldfaerwXgEUC", "citedby": "0"}, {"bib": {"title": "Supplementary Information for Development of Narrow Spectrum ATP-competitive Kinase Inhibitors as Probes for BIKE and AAK1"}, "source": "citations", "id_citations": "CZhQ1cgAAAAJ:RYcK_YlVTxYC", "citedby": "0"}]}